September 2, 2015 | HeartWare International announced that it has entered into a definitive agreement to acquire Valtech Cardio in a share deal. According to reports, Valtech’s shares could be worth as much as $800 million. Valtech develops a number of non-invasive solutions for the treatment of heart conditions. Valtech was founded in 1996 by CEO Yossi Gross and Yiftach Beinart.
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments